| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |